Abstract
The methods involved in delivering drugs to target sites will have significant impact on the effectiveness of the drugs release. Absorption of high concentration of drugs have some toxicity effect meanwhile having low concentration may prove how low the therapeutic benefit the drugs hold, putting aside other various drawbacks. This chapter outlines how nanotechnology has developed some advance drug delivery system and how the development moves along throughout the years for a better future of medical treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Acharya S, Sahoo SK (2011) PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63:170–183
Afergan E, Epstein H, Dahan R, Koroukhov N, Rohekar K, Danenberg HD, Golomb G (2008) Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. J Control Release 132:84–90
Albanell J, Baselga J (1999) Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer. Drugs Today (Barc) 35:931–946
Biswas S, Dodwadkar NS, Deshpande PP, Torchilin VP (2012) Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J Control Release 159(3):393–402
Caminade AM, Laurent R, Majoral JP (2005) Characterization of dendrimers. Adv Drug Deliv Rev 57:2130–2146
Czarnobaj K (2008) Preparation and characterization of silica xerogels as carriers for drugs. Drug Deliv 15:485–492
D’Emanuele A, Attwood D (2005) Dendrimer-drug interactions. Adv Drug Deliv Rev 57:2147–2162
Di Pasqua AJ, Wallner S, Kerwood DJ, Dabrowiak JC (2009) Adsorption of the Pt (II) anticancer drug carboplatin by mesoporous silica. Chem Biodivers 6:1343–1349
Duncan R (2006) Polymer conjugates as anticancer nanomedicines. Nat Rev 6:688–701
Duncan R, Izzo L (2005) Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57:2215–2237
Echeverria JC, Estella J, Barberia V, Musgo J, Garrido JJ (2010) Synthesis and characterization of ultra microporous silica xerogels. J Non-Cryst Solids 356:378–382
Ferrara N (2005) VEGF as a therapeutic target in cancer. Oncology 69(3):11–16
Gonzalez-Aramundiz JV, Cordeiro AS, Csaba N, Fuente MDL, Alonso MJ (2012) Nanovaccines: nanocarriers for antigen delivery. Biol Aujourdhui 206(4):249–261
Huang Y-F, Shangguan D, Liu H, Phillips JA, Zhang X, Chen Y, Tan W (2009) Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumour cells. ChemBioChem 10:862–868
Karra N, Benita S (2012) The ligand nanoparticle conjugation approach for targeted cancer therapy. Curr Drug Metab 13:1–20
Kim JK, Choi SH, Kim CO, Park JS, Ahn WS, Kim CK (2003) Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency. J Pharm Pharmacol 55:453–460
Kitchens KM, Kolhatkar RB, Swaan PW, Eddington ND, Ghandehari H (2006) Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling. Pharm Res 23(12):2818–2826
Kratz F, Warnecke A (2012) Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems. J Control Release 164(2):221–235
Kumari A, Yadav SK, Yadav SC (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B: Biointerfaces 75:1–18
Lukyanov AN, Torchilin VP (2004) Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 56:1273–1289
Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, Augst JT, Leong KW (2001) Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 70:399–421
Muller RH, Keck CM (2004) Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 113:151–170
Muller RH, Radtke M, Wissing SA (2002) Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121–128
Nevozhay D, Kanska U, Budzynska R, Boratynski J (2007) Current status of research on conjugates and related drug delivery systems in the treatment of cancer and other diseases. Postepy Hig Med Dosw 61:350–360
Paavola A, Kilpelainen I, Yliruusi J, Rosenberg P (2000) Controlled release injectable liposomal gel of ibuprofen for epidural analgesia. Int J Pharm 199(1):85–93
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751–760
Re**old NS, Chennazhi KP, Nair SV, Tamura H, Jayakumar R (2011) Biodegradable and thermo-sensitive chitosan-g-poly (N-vinylcaprolactam) nanoparticles as a 5-fluorouracil carrier. Carbohydr Polym 83:776–786
Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V (2006) Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116:1–27
Roberts JC, Bhalgat MK, Zera RT (1996) Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J Biomed Mater Res 30:53–65
Ross KA, Brenza TM, Binnebose AM, Phanse Y, Kanthasamy AG, Gendelman HE, Salem AK, Bartholomay LC, Bellaire BH, Narasimhan B (2015) Nano-enabled delivery of diverse payloads across complex biological barriers. J Control Release 219:548–559
Safdar A, Ma J, Saliba F, Dupont B, Wingard JR, Hachem RY, Mattiuzzi GN, Chandrasekar PH, Kontoyiannis DP, Rolston KV, Walsh TJ, Champlin RE, Raad II (2010) Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis. Medicine 89(4):236–244
Santos Giuberti C, Oliveira Reis EC, Rocha TGR, Leite EA, Lacerda RG, Ramaldes GA, Oliveira MC (2011) Study of the pilot production process of long-circulating and pH-sensitive liposomes containing cisplatin. J Liposome Res 21(1):60–69
Shah N, Steptoe RJ, Parekh HS (2011) Low-generation asymmetric dendrimers exhibit minimal toxicity and effectively complex DANN. J Pept Sci 17:470–478
Singh P, Gupta U, Asthana A, Jain NK (2008) Folate and Folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Bioconjug Chem 19:2239–2252
Smith DM, Simon JK, Baker JR Jr (2013) Applications of nanotechnology for immunology. Nat Rev Immunol 13:592–605
Steinmetz NF (2010) Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. Nanomedicine 6:634–641
Sunderland CJ, Stejert M, Talmadge JE, Derfus AM, Barry SE (2006) Targeted nanoparticles for detecting and treating cancer. Drug Dev Res 67:70–93
Suri SS, Fenniri H, Singh B (2007) Nanotechnology-based drug delivery systems. J Occup Med Toxicol 2:16
Tong Q, Li H, Li W, Chen H, Shu X, Lu X, Wang G (2011) In vitro and in vivo anti-tumor effects of gemcitabine loaded with a new drug delivery system. J Nanosci Nanotechnol 11:3651–3658
Turkova A, Roilides E, Sharland M (2011) Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy—is there a ‘right’ choice? Curr Opin Infect Dis 24:163–171
Uner M, Yener G (2007) Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine 2(3):289–300
Wei L, Hu N, Zhang Y (2010) Synthesis of polymer-mesoporous silica nanocomposites. Materials 3:4066–4079
Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H (2012) Nanoparticles as drug delivery systems. Pharmacol Rep 64:1020–1037
Wilson A (2015) Nanovaccine delivery systems in vaccine formulations. SM Vaccine Vaccin J 1(2):1008
Wissing SA, Kayser O, Muller RH (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56:1257–1272
Yeung CK, Shek SY, Yu CS, Kono T, Chan HH (2011) Liposome-encapsulated 0.5% 5-aminolevulinic acid with intense pulsed light for the treatment of inflammatory facial acne: a pilot study. Dermatol Surg 37:450–459
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Awang Saman, R., Iqbal, M. (2019). Nanotechnology-Based Drug Delivery Systems: Past, Present and Future. In: Siddiquee, S., Melvin, G., Rahman, M. (eds) Nanotechnology: Applications in Energy, Drug and Food. Springer, Cham. https://doi.org/10.1007/978-3-319-99602-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-99602-8_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99601-1
Online ISBN: 978-3-319-99602-8
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)